Colorado biotech seeks DEA approval for FDA-regulated whole-plant cannabis program

AJNA Biosciences applied for DEA registration to manufacture marijuana, extracts and THC for whole-plant cultivation, internal research, clinical trials and analytical work in an FDA-regulated drug program. The filing shows Oklahoma manufacturers and researchers the separate federal security, recordkeeping and registration path required for pharmaceutical development.